 BOSTON, April 28, 2022 GLOBE NEWSWIRE -- AVEO Oncology Nasdaq: AVEO, a commercial stage, oncology-focused biopharmaceutical company, today announced that it will report first quarter 2022 financial results on Thursday, May 5, 2022. AVEOs management team will host a conference call and audio webcast at 8:30 a.m. ET on Thursday, May 5, 2022, to discuss the financial results and provide a business update. 